Job Summary

• The role serves as the 'CEO' of the asset with overall accountability for the strategy, budget, timeline, and execution of a portfolio of pre-clinical and clinical stage therapeutic candidates.
• Candidates must demonstrate success in developing oncology agents with a strong understanding of diverse biological mechanisms including Immuno-Oncology, Antibody-drug Conjugates, and Cell Therapy.
• The position offers a competitive annual base pay ranging from $246,069.60 to $369,104.40 along with short-term incentives, equity-based long-term programs, and comprehensive health benefits.

Matching Summary

Salary

Base: $246,069.60 - $369,104.40; Bonus/Equity: Short-term incentive bonus and equity-based long-term incentive program available; Benefits: Qualified retirement program, paid vacation/holidays, medical, dental, vision coverage

Skills & Requirements

Key Requirements

• Graduate degree (PhD, PharmD, or MD/PhD)
• 10+ years leading oncology drug development
• Demonstrated success in early phase non-clinical and clinical development
• Regulatory knowledge and strategic leadership capability

Work Rights